Effects of Travoprost on Neovascular Glaucoma

Federal University of São Paulo

Status: Withdrawn

Conditions: Neovascular Glaucoma

Treatments: Drug: Travoprost

Study type: Interventional

Funder types: Other

Identifiers

NCT00441181

UNIFESP 2007-02

Details and patient eligibility

About

Prostaglandin analogues have not been used in the treatment of neovascular glaucoma because of suspicious lack of efficacy. This study aims at assessing the effect of travoprost on neovascular glaucoma.

Enrollment: 40 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Neovascular glaucoma of known cause
• Older than 18 years
• Previously submitted to retinal photocoagulation
• Under medical treatment to glaucoma

Exclusion criteria

• Need of antiglaucomatous surgery
• Previous ocular surgery in the last 6 months
• Pregnancy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind